Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
teprotumumab (Tepezza) (1 trial)
Edema (Phase 1)
Macular Edema (Phase 1)
Trials (1 total)
Trial APIs (1 total)